Genea Board of Directors
The Genea Board comprises a group of very experienced business professionals and doctors with extensive backgrounds in a range of financial and healthcare fields.
The Board is accountable to the Company’s shareholders for its performance.
Dr Robert Woolcott
Co-Chairman, Genea Board
Robert joined the Genea Board as a Non-Executive Director of Genea Limited in January 2011. He was elected joint Chairman of the Board in September 2019.
He is Chairman of the Medical Practice Committee, a member of the Audit Committee, the Risk and Compliance Committee and the Remuneration and Nominations Committee. He is Medical and Management Director of Genea Newcastle and Chief Medical Officer of Genea Biomedx.
Robert graduated as a Bachelor of Medicine/Bachelor of Surgery with honours in 1981 and has 33 years of experience in IVF and reproductive microsurgery. He undertook the Advanced Management Program at Harvard Business School in 2007.
He is a former member of the RANZCOG Reproductive Endocrinology and Infertility subspecialist sub-committee, the Hunter Post Graduate Medical Institute Board and the Mayne Health Medical Advisory Board.
Ka King (Eric) Cheng
Co-Chairman, Genea Board
Aldworth Equity Management Limited Founding Partner
Eric joined the Genea Board as an Executive Director in December 2018. He was elected joint Chairman of the Board in September 2019.
Eric is the Founding Partner of Aldworth Equity Management Limited and has over 28 years of experience in the banking industry with geographic coverage over China, Hong Kong, Macau and SE Asia. He has worked in various senior postings for BNP Paribas, Credit Suisse, UBS, Standard Chartered Bank and HSBC.
Eric graduated in 1990 with a Bachelor of Business Studies and obtained a Master of Finance from City University of Hong Kong.
Hoi Kwong (Eddie) Hon
Aldworth Equity Management Limited Partner and Chief Operating Officer
Eddie joined the Genea Board as an Executive Director in January 2019.
Eddie is the Partner and COO of Aldworth Equity Management Limited. He has over 20 years of experience in finance, banking, operations and business development. He has also previously held various senior positions in listed and multinational companies.
Eddie graduated with a Bachelor of Economics from the University of Hong Kong in 1996 achieved an MBA from the University of South Australia in 2014.
WeDoctor Co-founder and CSO
Mr Zhang Xiaochun co-founded WeDoctor with Liao Jieyuan in 2010 and now serves as its CSO. He has a master's degree from Dongbei University of Finance and Economics and has worked in the Internet industry since 2000. He was the former CEO of Galaxy Internet Television was also the general manager of CNR New Media, a subsidiary of CNR (China National Radio) Media Group.
Ni Zhijing (Kevin)
WeDoctor Finance Vice President
Mr Ni Zhijing (Kevin) is the Finance Vice President of WeDoctor. Graduated from Shanghai University of Finance and Economics, he joined Price Waterhouse Coopers in 2007. Kevin has extensive practical experience in audit and assurance service to private, MNC and state-owned entities in China. He has been involved in a variety of onshore and offshore IPOs, debt restructurings, and mergers & acquisitions projects. Kevin is a member of the Chinese Institute of Certified Public Accountants (“CICPA”).
Dr Tomas Stojanov
Genea Chief Executive Officer
Tomas was appointed Genea Chief Executive Officer in January 2011 and joined the Genea Board as an Executive Director at the same time.
With more than 26 years of experience in the health, biotechnology and agriculture sectors in a range of capacities, Tomas has conducted scientific research and has worked in operational management and commercialisation roles. Immediately prior to his appointment as CEO of Genea, Tomas was Director of Research and General Manager of Stem Cells and Research.